期刊文献+

大豆异黄酮对去卵巢大鼠主动脉晚期糖化终末产物(AGEs)及脂质过氧化的影响 被引量:13

Effects of Isoflavone (ISO) on Advanced Glycosylation End Products (AGEs) in Aortae and Serum Levels of Lipid Peroxide in Ovariectomized Rats
下载PDF
导出
摘要 目的:探讨大豆异黄酮对去卵巢(OVX)大鼠晚期糖化终未产物(AGEs)和血清脂质过氧化物的影响。方法:将6月龄雌性SD大鼠随机分为假手术组(Sham)、去卵巢组(OVX)和去卵巢+大豆异黄酮组(OVX+ISO)。去除双侧卵巢2周后治疗13周。禁食24h,取血,处死动物,取主动脉,分别测定主动脉AGEs含量、血脂和血清过氧化物含量。结果:与假手术组相比,去卵巢组主动脉AGEs,血清甘油三酯(TG)、氧化低密度脂蛋白(OX-LDL)和丙二醛(MDA)含量均明显升高,高密度脂蛋白-胆固醇(HDL-C)、载脂蛋白AI(apo-AI)和超氧化物歧化酶(SOD)活性均显著降低。大豆异黄酮明显调节这些改变。结论:大豆异黄酮通过降低去卵巢大鼠主动脉AGEs含量,血清OX-LDL和MDA水平,提高SOD活性,调节血脂,预防和减少动脉粥样硬化的发生。 Objective:To investigate effects of isoflavone(ISO) on advanced glycosylation end products (AGEs) and lipid peroxide of o-variectomized rats.Methods:Rats were randomly divided into sham group (Sham),ovariectomized group (OVX) and OVX+ ISO group. Rats were ovariectomized, And two weeks later, OVX + ISO group were treated with ISO.Levels of aortic AGEs, lipids and serum lipid peroxide were detected after 13 weeks of treatment.Results:The aortic AGEs,serum triglycerides (TG) ,oxidated-LDL (OX-LDL) and malondialdehyde (MDA) of the OVX group were higher ( P < 0.01, P < 0.05, P < 0.05 and P < 0.01 , respectively) and the levels of high density lipoprotein-cholesterol (HDL-C), apolipoproptein A I (apo-AI) and activity of superoxide dismutase (SOD) were lower (P< 0.01,all) than that of the sham group.ISO not only reduced the concentration of aortic AGEs, serum OX-LDL,TC and MDA (P< 0.01 ,P< 0.05,P< 0.05 and P< 0.05 respectively) , but also increased concentration of serum HDL-C,apo-AI and SOD activity (P< 0.01, all) . Conclusion;ISO could decrease aortic AGEs,serum MDA and OX-LDL,enhance SOD activity and adjust serum lipids,therefore it maybe helpful to cardiovascular system.
出处 《中药材》 CAS CSCD 北大核心 2003年第1期26-28,共3页 Journal of Chinese Medicinal Materials
关键词 大豆 异黄酮 晚期糖化终末产物 血清 脂质过氧化物 主动脉 Isoflavone AGEs Lipid peroxide Ovariectomy
  • 相关文献

参考文献4

二级参考文献18

  • 1孔德娟,李恩,陈永春,李芳芳,廖海东.晚期糖化终末产物对大鼠成骨细胞增殖和分化的影响[J].中国骨质疏松杂志,1999,5(3):29-32. 被引量:11
  • 2[1]Adlercreutz H. Scand J Clin Lab Invest, 1990;210(suppl): 3~23
  • 3[2]Campbell KL, Czamecki-Maulden GL, Schaeffer JD. Am J Vet Res, 1995; 56(11): 1465~1469
  • 4[3]Carroll KK, Kurowska EM. J Nutr, 1995; 125(3 suppl): 594S~597S
  • 5[4]Cassidy A, Bingham S, Setchell K, et al. Br J Nutr, 1995; 74(4) :587~601
  • 6[5]Forsythe WA. J Nutr, 1995; 125 (3 suppl):619S~623S
  • 7[6]Potter SM. Curr Opin Lipidol, 1996; 7(4):260~264
  • 8[7]Steinberg D. Circulation, 1997; 95(4):1062~1071
  • 9[8]Kapiotis S, Hermann M, Held I, et al. Arterioscler Thromb Vosc Biol, 1997; 17(11 ): 2868~2874
  • 10[9]Nestel PJ, Yamashita T, Sasahara T, et al.Arterioscler Thromb Vasc Biol, 1997; 17(12):3392~ 3398

共引文献24

同被引文献103

引证文献13

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部